Using the same bone metastasis model, zoledronate has been shown to markedly reduce the area of osteolytic lesions as detected by X-ray autoradindependentndependent of time of administration (concurrently with the tumour cell injections or after the establishment of bone metastasis) (Peyruchaud et al, 2001) and of the dose administered (0.2, 1 and 5 μg per mouse; Green et al, 2000).
Furthermore, for the era of cytotoxic chemotherapy, several schedules of administration were concurrently examined in different phase I trials, detailed pharmacokinetics studies were performed, and the recommended dose and schedule was largely based on an analysis of the safety profiles, pharmacokinetics considerations, and preliminary hints of activity.
Palmatier MI, Evans-Martin FF, Hoffman A, Caggiula AR, Chaudhri N, Donny EC, et al. Dissociating the primary reinforcing and reinforcement-enhancing effects of nicotine using a rat self-administration paradigm with concurrently available drug and environmental reinforcers.
The administration of sunitinib concurrently to radiation therapy will be the study intervention.
The differences in administration protocol were due to the fact that these 3 schedules of administration were being evaluated concurrently in dogs with NHL at the time these patients were treated [ 9].
Compared to vehicle, 6-weeks of GW501516 and PF-879 administration, either alone or concurrently, significantly decreased muscle triglycerides and serum free fatty acids (FFAs) in ob/ob mice, but had no effect on liver triglycerides (Figure 5A and Figure S2).
Of the 77 patients with a new diagnosis of sVARI, 51 (66%) were concurrently undergoing administration of broad spectrum antibiotics.
For these properties NSAIDs have been sporadically employed in clinical cancer therapy; more frequently, they are utilised as analgesic, occasionally concurrently chemotherapy administration without a profound knowledge of the potential interaction with anticancer drugs and their efficacy.
In our former study of a phase I/II study (Takeda et al, 1999) of weekly irinotecan alone and concurrent thoracic radiotherapy in patients with stage III NSCLC, radiation therapy (2 Gy daily to a total dose of 60 Gy) was performed concurrently with administration of irinotecan done once weekly for 6 weeks.
Concurrently, IL-18 administration resulted in a decrease in human CD4+CD25+FoxP3+ regulatory T cells (Tregs).
The inclusion of trastuzumab resulted in an improvement in DFS with an HR = 0.60 (95%CI 0.50 0.71), regardless of trastuzumab treatment duration or administration schedule (i.e. concurrently or sequentially with CT) and an improvement in OS with an HR = 0.66 (95%CI 0.57 0.77).
